Results 151 to 160 of about 3,249 (205)

Targeted and Personalized Therapy for Difficult Benign Brain Tumors: A Review. [PDF]

J Pers Med
Chliapnikov P, Bernstein M.
europepmc   +1 more source

Classification of schwannomas and the new naming convention for "neurofibromatosis-2": Genetic updates and international consensus recommendation. [PDF]

Neuroradiol J
Rai P, Bathla G, Soni N, Desai A, Rao D, Vibhute P, Agarwal A.   +6 more
europepmc   +1 more source

Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. [PDF]

Sci Rep
Spiegel JL, De Maio A, Patel MV, Ungar OJ, Lai C, Truong T, Situ Y, Clapp DW, Conway SJ, Chen JM, Lin VYW, Hynynen K, O'Reilly MA, Le TN.   +13 more
europepmc   +1 more source

Multiple spinal nerve sheath tumors in a dog resembling schwannomatosis in humans. [PDF]

J Vet Diagn Invest
Tse JL, Rebollada-Merino A, Pumarola M, Ortiz AL, Toni C.   +4 more
europepmc   +1 more source

Plexiform Schwannoma of the Middle Finger: A Rare Benign Mesenchymal Tumor Presenting as a Chronic Digital Swelling. [PDF]

Cureus
Pitambra A, Prabhala S, Somalwar SB, Ramavath K.   +3 more
europepmc   +1 more source

Conditioned medium from painful non-NF2 schwannomatosis tumors increases pain behaviors in mice. [PDF]

Sci Rep
Rubright R, Caterina MJ, Belzberg A, Ostrow KL.   +3 more
europepmc   +1 more source

Clinical and Genetic Overview of Neurofibromatosis Type 2 (NF2). [PDF]

J Korean Neurosurg Soc
Kim TK, Park YS, Nakagawa I.
europepmc   +1 more source

Advancements in Preclinical Models for NF2-Related Schwannomatosis Research. [PDF]

Cancers (Basel)
Zhang BS, Lu S, Plotkin SR, Xu L.
europepmc   +1 more source